NovaSeq 6000 Sequencing System is by far our most powerful instrument, designed to adapt to your needs.
Kits & Reagents
Enabling comprehensive genomic profiling from FFPE samples.
Selection & Planning Tools
A high-performing, fast, and integrated workflow for sensitive applications such as human whole-genome sequencing
Software & Informatics Products
DRAGEN v3.9 release now available with multi-cloud support, accuracy improvements and more
Fast, high-quality, sample-to-data services such as RNA and whole-genome sequencing
Find popular product groupings for your workflow
Our leaders are pioneers of genetic research and clinical applications. They are deeply committed to scientific accessibility, data, and community.
Next-generation sequencing is helping Native nations with sovereignty and genetic research
All Investor Information
All Legal Information
New page replaces MyIllumina Technical Updates email
All Support Tools
Product Support Services
Maximize identification of molecularly matched therapies with one biopsy, one test, one report
Cancer Research Products
Microbial Genomics Research
With the debut of the COVIDSeq Assay, smaller labs are participating in surveillance
Microbial Genomics Products
Identifying variants could help select highly productive breeds that adapt to rapidly changing climates
The most comprehensive genotyping microarray on the market for pharmacogenomic research now at 25% off, restrictions apply
Complex Disease Research Products
Comprehensive genomic profiling is driving innovation across the 51-hospital system
The collaboration will introduce VeriSeq NIPT Solution v2 in Southeast Asia
Reproductive Health Products
Illumina supports the release of a landmark consensus on whole-genome sequencing in the diagnosis of genetic diseases in newborns
Genetic Health Products
We can use aggregated alignment metrics from populations to predict how well we can call variants in any sample. This empirical approach finds very high quality regions and outperforms reference-based methods.
The Illumina Connected Analytics (ICA) platform is the foundation on which a customized genomics analysis environment is built, managing and processing large amounts of heterogenous data sets.
The DRAGEN platform calls both small and large variants from population genetics studies with high precision and speed.
DRAGEN recently won the PrecisionFDA Truth Challenge V2 contest for Illumina reads in the Difficult-to-Map and All-Benchmark Regions categories.
SMNCopyNumberCaller enables accurate copy number calling of the highly similar SMN1 and SMN2 for spinal muscular atrophy diagnosis/carrier screening.
SpliceAI, a 32-layer deep neural network, predicts splicing from pre-mRNA sequences and identifies cryptic splice variants in rare disease patients.
REViewer is a computational method for visualization of sequencing data in genomic regions containing long repeat expansions.
CYP2D6 metabolizes 21% of clinically used drugs. Cyrius resolves common SVs and sequence homology to paralog and genotypes CYP2D6 with 99.3% accuracy.
Paragraph is a graph aligner and variant caller that can accurately genotype known structural variants using the aligned sequence reads.
The Illumina team developed deep neural network algorithm, PrimateAI, to predict the clinical impact of human missense mutations.